Whether Trientine is included in the medical insurance reimbursement catalog and related policies

Trientine is a copper chelator used to treat Wilson's disease (Wilson's disease, also known as hepatolenticular degeneration). It is mainly used for patients who are intolerant or unable to use penicillamine. In recent years, the drug has been approved by the Food and Drug Administration in China for marketing, with the trade name "Coppeo®", becoming a new domestic option for the treatment of Wilson's disease. Its launch fills the gap in treatment options for some patients and provides more targeted treatment options for clinical use.

Although trientine has been marketed in China, it has not been included in the national medical insurance drug list so far. This means that patients need to purchase the drug at their own expense and cannot enjoy medical insurance reimbursement. This would be a significant financial burden for patients who need to take the drug long-term. Since it is not included in medical insurance, the domestic price of trientine has not yet been announced uniformly. It is recommended that patients consult the pharmacy of the hospital where they are treated for the latest drug purchase information and cost details.

In foreign countries, trientine has long been approved for use, especially the original drug produced in Germany (such asCuprior®). The specification is 200mg Such prices are unaffordable in the domestic market, which has also led some patients to choose to look for relatively cheaper alternative drugs through overseas channels. However, it should be noted that there are uncertainties in the legality, customs clearance risks, and drug quality assurance when purchasing drugs overseas. You need to understand from multiple parties before purchasing.

Taken together, although trientine has entered the domestic market, since it has not yet entered the medical insurance reimbursement system, the economic pressure on patients is still high. It is recommended that relevant departments evaluate its clinical value and actual patient needs when adjusting the medical insurance catalog in the future, and consider including it in a timely manner. At the same time, patients should fully consult a professional doctor before taking medication, and choose a treatment path that suits them based on their condition and financial situation to ensure both efficacy and safety.

Reference materials:https://www.drugs.com/